Ignite Creation Date:
2025-12-24 @ 4:34 PM
Ignite Modification Date:
2026-01-19 @ 12:59 PM
Study NCT ID:
NCT00463866
Status:
COMPLETED
Last Update Posted:
2010-03-22
First Post:
2007-04-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Local Phase 4 Pan-European SMART Study
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D5890L00022
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None